Overview

Evaluation of Etanercept in Patients With Plaque Psoriasis After Stopping Ciclosporin Therapy

Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the use of etanercept as a replacement therapy for ciclosporin in patients with plaque psoriasis.
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer
Treatments:
Cyclosporine
Cyclosporins
Etanercept